Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Jacob

Showing results (191-200 of 213) with videos related to

Pageof 22
Sort By:
European Journal of Pharmacology|June 8, 2024
Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemiaKeli Lima, Frederico Lisboa Nogueira, Marcella Cipelli, et al.
Science Advances|April 14, 2023
M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolismIsabel Weinhäuser, Diego A Pereira-Martins, Luciana Y Almeida, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 19, 2015
Molecular Fluorescence Endoscopy Targeting Vascular Endothelial Growth Factor A for Improved Colorectal Polyp DetectionJolien J Tjalma, P Beatriz Garcia-Allende, Elmire Hartmans, et al.
Cancer Cell|September 25, 2018
Prospective Isolation and Characterization of Genetically and Functionally Distinct AML SubclonesBauke de Boer, Janine Prick, Maurien G Pruis, et al.
Cell Reports. Medicine|January 9, 2026
ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemiaDiego A Pereira-Martins, Cesar Ortiz, Isabel Weinhäuser, et al.
Gut|April 15, 2019
Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort studyArne Gc Bleijenberg, Joep Eg IJspeert, Yasmijn J van Herwaarden, et al.
Blood Neoplasia|April 20, 2026
Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemiaNiels Westra, Elena Ropero Cerro, Edwin Schilder, et al.
Leukemia|November 7, 2023
PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemiaIslam Alshamleh, Nina Kurrle, Philipp Makowka, et al.
EMBO Molecular Medicine|June 25, 2020
Innovations, challenges, and minimal information for standardization of humanized miceRenata Stripecke, Christian Münz, Jan Jacob Schuringa, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2024
Faecal Volatile Organic Compounds to Detect Colorectal Neoplasia in Lynch Syndrome-A Prospective Longitudinal Multicentre StudyElsa L S A van Liere, Dewkoemar Ramsoekh, Emma Daulton, et al.
Pageof 22

Showing results (191-200 of 213) with videos related to

Sort By:
Pageof 22
European Journal of Pharmacology|June 8, 2024
Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemiaKeli Lima, Frederico Lisboa Nogueira, Marcella Cipelli, et al.
Science Advances|April 14, 2023
M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolismIsabel Weinhäuser, Diego A Pereira-Martins, Luciana Y Almeida, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 19, 2015
Molecular Fluorescence Endoscopy Targeting Vascular Endothelial Growth Factor A for Improved Colorectal Polyp DetectionJolien J Tjalma, P Beatriz Garcia-Allende, Elmire Hartmans, et al.
Cancer Cell|September 25, 2018
Prospective Isolation and Characterization of Genetically and Functionally Distinct AML SubclonesBauke de Boer, Janine Prick, Maurien G Pruis, et al.
Cell Reports. Medicine|January 9, 2026
ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemiaDiego A Pereira-Martins, Cesar Ortiz, Isabel Weinhäuser, et al.
Gut|April 15, 2019
Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort studyArne Gc Bleijenberg, Joep Eg IJspeert, Yasmijn J van Herwaarden, et al.
Blood Neoplasia|April 20, 2026
Pharmacological boosting of azacitidine/venetoclax in acute myeloid leukemiaNiels Westra, Elena Ropero Cerro, Edwin Schilder, et al.
Leukemia|November 7, 2023
PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemiaIslam Alshamleh, Nina Kurrle, Philipp Makowka, et al.
EMBO Molecular Medicine|June 25, 2020
Innovations, challenges, and minimal information for standardization of humanized miceRenata Stripecke, Christian Münz, Jan Jacob Schuringa, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2024
Faecal Volatile Organic Compounds to Detect Colorectal Neoplasia in Lynch Syndrome-A Prospective Longitudinal Multicentre StudyElsa L S A van Liere, Dewkoemar Ramsoekh, Emma Daulton, et al.
Pageof 22